Circle Connections: Tech Updates Brainsway has signed on with an undisclosed U.S. distributor to expand the adoption of its Deep TMS system, a non-invasive treatment cleared to treat drug- resistant depression. The partner will lease about 200 of the devices over up to three years, the company said, and Brainsway will keep up its direct-lease sales efforts all the while. Deep TMS won FDA approval in January, and the device is already CE marked to treat depression, Alzheimer's and autism, among other indications. Brainsway's treatment is an implant-free take on deep-brain stimulation, applying . . .